Form 4: GoodRx Holdings Executive Scott Wagner Reports Stock Transactions

Scott Wagner, Interim CEO of GoodRx Holdings, reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units on August 8, 2024.

Summary

• On August 8, 2024, Scott Wagner, Interim CEO of GoodRx Holdings, reported transactions involving Class A Common Stock and Restricted Stock Units.
• Wagner acquired 70,591 shares of Class A Common Stock through the exercise of Restricted Stock Units.
• He also disposed of 35,776 shares of Class A Common Stock to cover tax obligations at a price of $8.61 per share.
• Following these transactions, Wagner directly owns 149,849 shares of Class A Common Stock and indirectly owns 182,900 shares through the Wagner Family Trust.
• He also directly owns 282,366 Restricted Stock Units.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard regulatory filing reporting stock transactions. There's no inherent positive or negative implication.

Industry Context

This Form 4 filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel and their holdings in the company.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership by a key executive.
• The transactions have no direct impact on employees, customers, suppliers, or creditors.

Key Dates